CN104258351A - 一种治疗酒精性心肌病的中药制剂及其制备方法 - Google Patents
一种治疗酒精性心肌病的中药制剂及其制备方法 Download PDFInfo
- Publication number
- CN104258351A CN104258351A CN201410535988.1A CN201410535988A CN104258351A CN 104258351 A CN104258351 A CN 104258351A CN 201410535988 A CN201410535988 A CN 201410535988A CN 104258351 A CN104258351 A CN 104258351A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- preparation
- rhizoma
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 63
- 201000010053 Alcoholic Cardiomyopathy Diseases 0.000 title claims abstract description 32
- 206010007637 Cardiomyopathy alcoholic Diseases 0.000 title claims abstract description 32
- 238000002360 preparation method Methods 0.000 title claims abstract description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 34
- 239000009636 Huang Qi Substances 0.000 claims description 24
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 15
- 241000628997 Flos Species 0.000 claims description 13
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 9
- 239000002775 capsule Substances 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 239000000706 filtrate Substances 0.000 claims description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 238000001556 precipitation Methods 0.000 claims description 4
- 239000011230 binding agent Substances 0.000 claims description 2
- 238000009835 boiling Methods 0.000 claims description 2
- 229910052742 iron Inorganic materials 0.000 claims description 2
- 238000004064 recycling Methods 0.000 claims description 2
- 238000012546 transfer Methods 0.000 claims description 2
- 238000001291 vacuum drying Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 39
- 239000008280 blood Substances 0.000 abstract description 34
- 210000004369 blood Anatomy 0.000 abstract description 34
- 210000004185 liver Anatomy 0.000 abstract description 25
- 235000006533 astragalus Nutrition 0.000 abstract description 3
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract description 2
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract description 2
- 244000075634 Cyperus rotundus Species 0.000 abstract description 2
- 241000931143 Gleditsia sinensis Species 0.000 abstract description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract description 2
- 244000236658 Paeonia lactiflora Species 0.000 abstract description 2
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract description 2
- 244000197580 Poria cocos Species 0.000 abstract description 2
- 235000008599 Poria cocos Nutrition 0.000 abstract description 2
- 244000046146 Pueraria lobata Species 0.000 abstract description 2
- 241000220317 Rosa Species 0.000 abstract description 2
- 244000273928 Zingiber officinale Species 0.000 abstract description 2
- 235000006886 Zingiber officinale Nutrition 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract description 2
- 235000008397 ginger Nutrition 0.000 abstract description 2
- WTPPRJKFRFIQKT-UHFFFAOYSA-N 1,6-dimethyl-8,9-dihydronaphtho[1,2-g][1]benzofuran-10,11-dione;1-methyl-6-methylidene-8,9-dihydro-7h-naphtho[1,2-g][1]benzofuran-10,11-dione Chemical compound O=C1C(=O)C2=C3CCCC(=C)C3=CC=C2C2=C1C(C)=CO2.O=C1C(=O)C2=C3CCC=C(C)C3=CC=C2C2=C1C(C)=CO2 WTPPRJKFRFIQKT-UHFFFAOYSA-N 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241001061264 Astragalus Species 0.000 abstract 1
- 235000010110 Astragalus glycyphyllos Nutrition 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 244000236521 Bupleurum rotundifolium Species 0.000 abstract 1
- 235000015221 Bupleurum rotundifolium Nutrition 0.000 abstract 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 abstract 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 abstract 1
- 235000009685 Crataegus X maligna Nutrition 0.000 abstract 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 abstract 1
- 235000009486 Crataegus bullatus Nutrition 0.000 abstract 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract 1
- 235000009682 Crataegus limnophila Nutrition 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract 1
- 235000002313 Crataegus paludosa Nutrition 0.000 abstract 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 abstract 1
- 244000150195 Cyperus longus Species 0.000 abstract 1
- 235000018109 Cyperus longus Nutrition 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 244000246386 Mentha pulegium Species 0.000 abstract 1
- 235000016257 Mentha pulegium Nutrition 0.000 abstract 1
- 235000004357 Mentha x piperita Nutrition 0.000 abstract 1
- 235000010575 Pueraria lobata Nutrition 0.000 abstract 1
- 235000005010 Scirpus paludosus Nutrition 0.000 abstract 1
- 241000316342 Taxillus Species 0.000 abstract 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 abstract 1
- 235000001050 hortel pimenta Nutrition 0.000 abstract 1
- 244000132619 red sage Species 0.000 abstract 1
- 239000009910 sargent gloryvine Substances 0.000 abstract 1
- 239000003053 toxin Substances 0.000 abstract 1
- 231100000765 toxin Toxicity 0.000 abstract 1
- 108700012359 toxins Proteins 0.000 abstract 1
- 210000000952 spleen Anatomy 0.000 description 29
- 230000001737 promoting effect Effects 0.000 description 25
- 239000000796 flavoring agent Substances 0.000 description 19
- 235000019634 flavors Nutrition 0.000 description 19
- 208000002193 Pain Diseases 0.000 description 17
- 230000017531 blood circulation Effects 0.000 description 16
- 230000036407 pain Effects 0.000 description 16
- 235000009508 confectionery Nutrition 0.000 description 14
- 229940079593 drug Drugs 0.000 description 14
- 230000007812 deficiency Effects 0.000 description 13
- 210000002216 heart Anatomy 0.000 description 12
- 210000002784 stomach Anatomy 0.000 description 12
- 208000011580 syndromic disease Diseases 0.000 description 12
- 230000004087 circulation Effects 0.000 description 11
- 210000004072 lung Anatomy 0.000 description 10
- 230000002107 myocardial effect Effects 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 231100000614 poison Toxicity 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 239000007789 gas Substances 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 210000003205 muscle Anatomy 0.000 description 7
- 230000001225 therapeutic effect Effects 0.000 description 7
- 206010007247 Carbuncle Diseases 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 6
- 208000008454 Hyperhidrosis Diseases 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 210000004165 myocardium Anatomy 0.000 description 6
- 230000001717 pathogenic effect Effects 0.000 description 6
- 230000001105 regulatory effect Effects 0.000 description 6
- 239000003440 toxic substance Substances 0.000 description 6
- 208000006820 Arthralgia Diseases 0.000 description 5
- 208000033809 Suppuration Diseases 0.000 description 5
- 210000000038 chest Anatomy 0.000 description 5
- 208000031225 myocardial ischemia Diseases 0.000 description 5
- 208000007848 Alcoholism Diseases 0.000 description 4
- 206010019280 Heart failures Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 206010003119 arrhythmia Diseases 0.000 description 4
- 230000006793 arrhythmia Effects 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000003014 reinforcing effect Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 230000035900 sweating Effects 0.000 description 4
- 235000019640 taste Nutrition 0.000 description 4
- 210000003462 vein Anatomy 0.000 description 4
- 206010002383 Angina Pectoris Diseases 0.000 description 3
- 206010022998 Irritability Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 208000025747 Rheumatic disease Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 239000003146 anticoagulant agent Substances 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 210000000170 cell membrane Anatomy 0.000 description 3
- 210000004351 coronary vessel Anatomy 0.000 description 3
- 230000002950 deficient Effects 0.000 description 3
- 239000002934 diuretic Substances 0.000 description 3
- 230000001882 diuretic effect Effects 0.000 description 3
- 230000035622 drinking Effects 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000000552 rheumatic effect Effects 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 241000382455 Angelica sinensis Species 0.000 description 2
- 206010002660 Anoxia Diseases 0.000 description 2
- 241000976983 Anoxia Species 0.000 description 2
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 2
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 2
- 241000045403 Astragalus propinquus Species 0.000 description 2
- 206010008479 Chest Pain Diseases 0.000 description 2
- 235000017159 Crataegus pinnatifida Nutrition 0.000 description 2
- 241000657480 Crataegus pinnatifida Species 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 241001278898 Glycyrrhiza inflata Species 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 241000207923 Lamiaceae Species 0.000 description 2
- 241001072983 Mentha Species 0.000 description 2
- 240000007164 Salvia officinalis Species 0.000 description 2
- FINHMKGKINIASC-UHFFFAOYSA-N Tetramethylpyrazine Chemical compound CC1=NC(C)=C(C)N=C1C FINHMKGKINIASC-UHFFFAOYSA-N 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000007953 anoxia Effects 0.000 description 2
- 230000001142 anti-diarrhea Effects 0.000 description 2
- 230000001166 anti-perspirative effect Effects 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 239000003213 antiperspirant Substances 0.000 description 2
- 230000001174 ascending effect Effects 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 230000004217 heart function Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 235000021374 legumes Nutrition 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 210000003463 organelle Anatomy 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 231100000572 poisoning Toxicity 0.000 description 2
- 230000000607 poisoning effect Effects 0.000 description 2
- 238000004393 prognosis Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 230000025102 vascular smooth muscle contraction Effects 0.000 description 2
- JLTCWSBVQSZVLT-CDIPANDDSA-N (2s)-n-[(2s)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosan Chemical compound NCCCC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](N)CSSC1.C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 JLTCWSBVQSZVLT-CDIPANDDSA-N 0.000 description 1
- 108091006112 ATPases Proteins 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 241001290610 Abildgaardia Species 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 102000057290 Adenosine Triphosphatases Human genes 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 241000092665 Atractylodes macrocephala Species 0.000 description 1
- 208000000412 Avitaminosis Diseases 0.000 description 1
- 241000510654 Bupleurum chinense Species 0.000 description 1
- 241000213015 Bupleurum scorzonerifolium Species 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 244000080208 Canella winterana Species 0.000 description 1
- 235000008499 Canella winterana Nutrition 0.000 description 1
- 241000282461 Canis lupus Species 0.000 description 1
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- 208000006029 Cardiomegaly Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 235000021511 Cinnamomum cassia Nutrition 0.000 description 1
- 241000756943 Codonopsis Species 0.000 description 1
- 206010056370 Congestive cardiomyopathy Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000125183 Crithmum maritimum Species 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 201000010046 Dilated cardiomyopathy Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 102000001390 Fructose-Bisphosphate Aldolase Human genes 0.000 description 1
- 108010068561 Fructose-Bisphosphate Aldolase Proteins 0.000 description 1
- -1 GOT) Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019668 Hepatic fibrosis Diseases 0.000 description 1
- 206010019705 Hepatic pain Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010021135 Hypovitaminosis Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 101710088105 Isocitrate dehydrogenase [NAD] subunit 1, mitochondrial Proteins 0.000 description 1
- 101710086399 Isocitrate dehydrogenase [NAD] subunit 2, mitochondrial Proteins 0.000 description 1
- 102100021332 Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial Human genes 0.000 description 1
- 241001083838 Lardizabalaceae Species 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 241000244365 Ligusticum sinense Species 0.000 description 1
- 241000221040 Loranthaceae Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 102000013460 Malate Dehydrogenase Human genes 0.000 description 1
- 108010026217 Malate Dehydrogenase Proteins 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 235000014435 Mentha Nutrition 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010034568 Peripheral coldness Diseases 0.000 description 1
- 241000222640 Polyporus Species 0.000 description 1
- 102000005320 Posterior Pituitary Hormones Human genes 0.000 description 1
- 108010070873 Posterior Pituitary Hormones Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 240000006066 Rosa rugosa Species 0.000 description 1
- 235000000659 Rosa rugosa Nutrition 0.000 description 1
- 235000017276 Salvia Nutrition 0.000 description 1
- 241000501113 Sargentodoxa cuneata Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 241000576755 Sclerotia Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
- 241000316341 Taxillus chinensis Species 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 102000005937 Tropomyosin Human genes 0.000 description 1
- 108010030743 Tropomyosin Proteins 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 239000003416 antiarrhythmic agent Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 230000035568 catharsis Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 230000001447 compensatory effect Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 210000000713 mesentery Anatomy 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000003680 myocardial damage Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 230000036513 peripheral conductance Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 238000000518 rheometry Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 210000001908 sarcoplasmic reticulum Anatomy 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 230000005586 smoking cessation Effects 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 229940046001 vitamin b complex Drugs 0.000 description 1
- 208000030401 vitamin deficiency disease Diseases 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
- 239000001841 zingiber officinale Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/483—Gleditsia (locust)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/55—Liquid-liquid separation; Phase separation
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗酒精性心肌病的中药制剂,它是由葛根、丹参、黄芪、柴胡、当归、白芍、炒白术、茯苓、干姜、薄荷、玫瑰花、皂角刺、大血藤、桑寄生、炒山楂、川芎、肉桂、香附、生甘草按照一定的重量配比制成,具有解毒散瘀,补气升阳,疏肝解郁的功效,能够有效治疗酒精性心肌病。
Description
技术领域
本发明涉及一种中药制剂,具体涉及一种治疗酒精性心肌病的中药胶囊剂,本发明还涉及该中药制剂的制备方法。
背景技术
酒精性心肌病(alcoholic cardiomyopathy.ACM)指发病与长期大量的酒精摄入有密切关系,具有典型扩张型心肌病的血流动力学变化、症状、体征及影像学所见,多发生于 30~55 岁的男性,通常有 10年以上过度嗜酒史,酒精摄入量每日超过125ml,临床表现多样化,主要表现为心功能不全和心律失常,包括心脏扩大、充血性心力衰竭、心律失常、胸痛、血压改变等主要症状。
酒精性心肌病是由于乙醇及其代谢产物乙醛等对心肌直接毒害的结果。酒精对心肌细胞的直接毒性作用主要表现在以下几方面:1、乙醇损害心肌细胞膜的完整性,系通过酒精脂溶性的生物学特性,侵袭细胞膜引起液化作用及改变细胞膜脂肪成分和分子构型,使膜表面离子分布和膜电位失控,影响细胞间信息传递和离子交换;2、乙醇的代谢产物可与许多蛋白结合,影响细胞器功能,包括线粒体、肌浆网等细胞器功能失调,以致心肌能源供应减少;3、影响心肌细胞离子的通透性,从而使钾、磷酸盐或镁从心肌中丢失,而心肌细胞内钙离子超载,可导致心肌收缩力下降,是引起酒精性心肌病心功能不全的重要原因;4、酒精代谢时引起中间代谢的改变,使三羧基酸循环中某些酶如天门冬氨酸氨基转移酶(谷草转氨酶)、苹果酸脱氢酶、异枸橼酸脱氢酶、乳酸脱氢酶和醛缩酶从心肌细胞中逸出,必影响心肌细胞功能,使它不能有效地利用脂肪酸产生能量,并使三酰甘油在心肌中堆积,脂肪运转异常和肌原纤维的三磷酸腺苷酶活性改变,对心肌本身具有直接抑制作用;5、长期饮酒可变更调节蛋白(原宁蛋白和原肌凝蛋白)的结构,影响心肌舒缩功能;6、长期大量饮酒尚可造成人体均衡营养失调,易导致维生素缺乏,尤其是维生素B族缺乏,也可加重心功能不全;7、此外,酒类的某些添加剂中含有钴、铅等有毒物质,长期饮用可引起中毒或心肌损伤。由于上述原因的相互作用和影响,最终可导致酒精性心肌病的发生。
本病治疗的关键是戒酒。在戒酒的同时,积极劝说戒烟,以改善预后。目前西医主要是以利尿药,抗心律失常药为主,中医治疗并没有针对酒精性心肌病的辩证分型,而是多从心肌病的证型进行论治。心肌病的中医辩证分型有:心气虚弱证、气阴两虚证、气阳两虚证,酒精性心肌病属于邪实为主预后好,目前的临床多从虚证论治,使得该病实者复实之,往往导致事倍功半。
发明内容
本发明的目的在于提供一种治疗酒精性心肌病的中药制剂,该中药制剂对于酒精性心肌病具有疗效好,治疗方式简单,治愈率高,价格低廉,不易反复的特点。
本发明的另一目的是提供该治疗酒精性心肌病的中药制剂的制备方法。
发明人在多年的临床医疗实践中,观察到酒精性心肌病给患者带来的痛苦,根据该病症的发展规律,以及中药的配伍原则,并通过大量的临床验证,反复探索总结出一种治疗酒精性心肌病的中药制剂的新配方。本发明具有疗效好,治疗方式简单,治愈率高,价格低廉,不易反复的特点。
本发明选择葛根、丹参、黄芪、柴胡、当归、白芍、炒白术、茯苓、干姜、薄荷、玫瑰花、皂角刺、大血藤、桑寄生、炒山楂、川芎、肉桂、香附、生甘草进行组合,将这些药物组合使得各药物功效产生协同作用,使之具有解毒散瘀,补气升阳,疏肝解郁的功效,从而能够有效治疗酒精性心肌病。
本发明中药物的作用:
其中:
葛根:为豆科植物野葛 Pueraria lobata (Willd.)Ohwi 的干燥根。性味凉,甘、辛。入脾、胃经。功效:解表退热,生津,透疹,升阳止泻。葛根甘辛性凉,轻扬升散,入脾胃经,有发汗解表,解肌退热之功。现代药理学研究表明葛根中提出的黄酮能增加脑及冠状血管血流量,对垂体后叶素所引起的心脏缺血反应均有保护作用。临床应用用于治疗冠心病、心绞痛具有明显的效果。
丹参:为双子叶植物唇形科Labiatae鼠尾草属植物丹参Salvia /miltiorrhizaBge的干燥根及根茎。性味:苦,微寒。归经:入心、肝经。功效:活血调经,祛瘀止痛,凉血消痈,清心除烦,养血安神。用于胸肋胁痛,风湿痹痛,症瘕结块。《日华子本草》:养神定志,通利关脉。治冷热劳,骨节疼痛,四肢不遂;排脓止痛,生肌长肉;破宿血,补新生血;安生胎,落死胎;止血崩带下,调妇人经脉不匀,血邪心烦;恶疮疥癣,瘿赘肿毒,丹毒;头痛,赤眼,热温狂闷。丹参能活血祛瘀,对消除肝脏纤维结缔组织的增生,也可能有一定的作用。近代医学实验证明,丹参还具有抗血小板凝聚、降低血液黏度及调节内外凝血系统的功能。
黄芪:为豆科植物蒙古黄芪 Astragalus membranaceus (Fisch.) Bge. var. mongholicus (Bge.)Hsiao 或膜荚黄芪 Astragalus membranaceus (Fisch.) Bge.的干燥根。性味:甘,微温。归肺、脾、肝、肾经。功效:补气升阳、固表敛汗、利水消肿、托疮排脓、通调水道。在《本草汇言》中有记载:“黄芪,补肺健脾,实卫敛汗,驱风运毒之药也。故阳虚之人,自汗频来,乃表虚而腠理不密也,黄芪可以实卫而敛汗;伤寒之证,行发表而邪汗不出,乃里虚而正气内乏也,黄芪可以济津以助汗;贼风之疴,偏中血脉而手足不随者,黄芪可以荣筋骨;痈疡之证,脓血内溃,阳气虚而不敛者,黄芪可以生肌肉,又阴疮不能起发,阳气虚而不愈者,黄芪可以生肌肉。”黄芪擅长补中益气,为补气升阳要药,凡脾胃气虚,短期多汗者皆可随证配用。
柴胡:为伞形科多年生草本植物柴胡Bupleurum chinense DC.(北柴胡)或狭叶柴胡Bupleurum scorzonerifolium Willd.(南柴胡)的根或全草。性味:苦、辛、微寒。归肝、胆经。功效:和解退热、疏肝解郁、升阳举陷。柴胡具有良好的疏肝解郁的作用,为治疗肝气郁滞的要药,柴胡一药,还具有轻清升散,又能疏泄的特点。既能透表退热、疏肝解郁,又可用于升举阳气。因此,它在临床上是一味既可用于实症,又可用于虚症的药物。
当归:为伞形科植物当归 Angelica sinensis (Oliv.) Diels 的干燥根。性味甘、辛、苦,温。归肝、心、脾经。功效:补血;活血;调经止痛;润燥滑肠。“黄芪与当归,有相须之理。”黄芪大补肺脾之气,有固外之能;当归益血和营,是血家气药,以辛升运行为用,以温和辛润为功。二味合之,便能阳生阴长,故调治外伤内损伤科疾病,无论气虚血亏,有无发热,多用归、芪相配。据《本草正》载:“其味甘而重,故专能补血,其气轻而辛,故又能行血,能养营养血,补气生精,安五脏,强形体,益神志,凡有形虚损之病,无所不宜。”故临床上用于血虚萎黄、眩晕心悸、虚寒腹痛、风湿痹痛、跌扑损伤、痈疽疮疡。
白芍:为双子叶植物毛茛科植物芍药Paeonia lactiflora Pall. 的干燥根。性味:凉,苦酸,微寒。功效:补血柔肝、平肝止痛,敛阴收汗。研究表明:白芍中含有的芍药甙有抗菌、解热、抗炎、增加冠状动脉流量、改善心肌营养血流、扩张血管、对抗急性心肌缺血、抑制血小板聚集、镇静、镇痛、解痉、抗溃疡、调节血糖的作用。
炒白术:为菊科植物白术Atractylodes macrocephala Koidz.的干燥根茎。性味:苦、甘,温。归脾、胃经。功效:健脾益气,燥湿利水,止汗,安胎,白术和茯苓配合使用,健脾渗湿以资化生之源,助党参益气补脾。白术既能补气健脾,又能燥湿利水,为健脾燥湿的要药。白术甘温补中,能补气健脾,还可固表止汗,和黄芪、太子参配伍,共奏补脾肺之功。同治虚劳,劳倦乏力者。
茯苓:为多孔菌科真菌茯苓 Poria cocos (Schw.) Wolf 的干燥菌核。性味:甘、淡、平。归心、肺、脾、肾经。功效:利水渗湿,健脾宁心。本品甘补淡渗,既补又利,作用和缓,性平而无寒热之偏,为利水渗湿之要药。治疗水湿内行的水肿时,常配泽泻、猪苓。茯苓煎剂有明显镇静作用。《药征》:“主治悸及肉瞤筋惕,旁治头眩烦躁。” 本品通过益心脾而安心神。多用于心脾两虚,气血不足之心神不安。
干姜:为姜科植物姜Zingiber officinale Rosc.的干燥根茎。性味:辛、热。归脾、胃、心、肺经。功效:温中散寒,回阳通脉,燥湿消痰,温肺化饮。用于脘腹冷痛,呕吐泄泻,肢冷脉微,痰饮喘咳。干姜外用治疗外伤化脓性感染。品辛热燥烈、主入脾胃经,长于温暖中焦脾阳而散寒,故凡中焦寒证,无论外寒内侵之实寒证,还是阳气不足之虚寒证,均为要药。
薄荷:为唇形科(Labiatae)多年生宿根性草本植物薄荷属(Mentha)的地上部分。性味:辛、凉。归肺、肝经。功效:疏风散热,清头目,利咽喉,透疹毒,疏肝解郁。本品味辛行气,又能入肝经,故能疏肝解郁,常配伍柴胡、当归。
玫瑰花:为蔷薇科植物玫瑰 Rosa rugosa Thunb. 的干燥花蕾。性味:温、甘、微苦。归肝、脾、胃经。功效:行气解郁,和血,止痛,强肝养胃,活血调经,润肠通便,解郁安神。主治:胸膈满闷,胃脘、胁肋、乳房胀痛,月经不调,赤白带下。泄泻痢疾,跌打损伤,风痹,痈肿。《本草正义》中记载:玫瑰花香气最浓,清而不浊,和而不猛,柔肝醒胃,流气活血,宣通壅滞而绝无辛温刚燥之弊,推断气分药之中,最有捷效而最为驯良者,芳香诸品,殆无其匹。
皂角刺:为豆科植物皂荚Gleditsia sinensis Lam. 的干燥棘刺。性味:辛,温。归肺、肝经。功效:消肿排脓,活血祛风。中医临床用于痈疽肿毒均有较好的治疗效果,一般表现为脓未成者可消,脓已成者可使之速溃。
大血藤:为木通科植物大血藤 Sargentodoxa cuneata (Oliv.) Rehd. et wils. 的干燥藤茎。性味:苦、平。归肝、大肠经。功效:败毒消痈,活血通络,祛风杀虫,抑菌作用。红藤苦平,长于清热解毒,消痈止痛,疮家要药。清热解毒,活血,祛风。用于肠痈腹痛、经闭痛经、风湿痹痛、跌打扑痛。
桑寄生:为桑寄生科植物桑寄生Taxillus chinensis (DC.)Danser 的干燥带叶茎枝。性味:苦、甘,平。归肝、肾经。功效:补肝肾,强筋骨,祛风湿,安胎元,药理学研究表明:桑寄生可以降低缺血心肌中的cAMP或阻断其作用的有害环节,可对抗心律失常,减轻心肌缺血的程度,并且对心肌梗塞也有一定的治疗作用。
炒山楂:为蔷薇科植物山里红Crataegus pinnatifida Bge.var.major N.E.Br.或山楂Crataegus pinnatifida Bge.的干燥成熟果实。性味:酸、甘、微温。归脾、胃、肝经。功效:消食健胃,行气散瘀。用于肉食积滞,胃脘胀满,泻痢腹痛,瘀血经闭,产后瘀阻,心腹刺痛,疝气疼痛;高脂血症。现代药理研究表明:山楂内所含的三萜酸能改善冠脉循环而使冠状动脉性衰竭得以代偿,达到强心作用。另外山楂可增加冠脉流量,降低心肌耗氧量,对心肌缺血、缺氧有保护作用。
川芎:为伞形科植物川芎Ligusticum chuanxiong Hort.的干燥根茎。性味:辛,温。归肝、胆、心经。功效:活血行气,祛风止痛。本品辛散温通,能上行巅顶,下达血海,外彻皮毛,旁通四肢,既能活血又能行气,昔人谓川芎为血中之气药,殆言其寓辛散、解郁、通达、止痛等功能,若心脉瘀阻,胸痹心痛,则常与桂枝、丹参等同用。本品含有川芎嗪能抑制血管平滑肌收缩,扩张冠状动脉,增加冠脉血流量,改善心肌缺氧状况及肠系膜微循环,增加脑及肢体血流量,降低外周血管阻力,还能抑制血小板聚集,可预防血栓的形成,对心脑血管疾病有很好的疗效。
肉桂:为樟科植物肉桂Cinnamomum cassia Presl的树皮。性味大热,辛、甘。归肾、脾、心、肝经。功效:补火助阳,引火归源,散寒止痛,活血通经,通血脉。肉桂长于温里止痛,入下焦而补肾阳,归命火。
香附:为莎草科植物莎草Cyperus rotundus L. 的干燥根茎。性味:辛、微苦、微甘,平。归肝、脾、三焦经。功效:行气解郁,调经止痛,安胎,理气舒郁,调和肝胃。本品辛散苦泄,为疏肝理气之要药,可用于肝气郁滞所致诸痛证。
生甘草:为豆科植物甘草 Glycyrrhiza uralensis Fisch.,胀果甘草 Glycyrrhiza Inflata Bat.或光果甘草Glycyrrhiza Glabra L.的干燥根及根茎。性味甘,平。归心、肺、脾、胃经。功效:补脾和胃,益气复脉。《日华子本草》:安魂定魄。补五劳七伤,一切虚损、惊悸、烦闷、健忘。通九窍,利百脉,益精养气,壮筋骨,解冷热。
本发明的方解是:方中葛根升阳止泻、解肌退热,丹参活血调经、养血安神,黄芪补气升阳,补中益气,柴胡升阳举陷、疏肝解郁,即可治疗实证,又可治疗虚证,当归补血活血,益血和营,配合黄芪能阳生阴长,治疗眩晕心悸,以上五味共奏补气升阳,疏肝解郁,解毒散瘀之功,药中主要成分在临床上可以改善心肌缺氧状况,还有对心肌细胞具有一定的修复和保护作用,对酒精性心肌病的各种症状起到根本的治疗作用。白芍、白术补血柔肝、健脾益气,茯苓健脾宁心,干姜回阳通脉,薄荷助柴胡、当归疏肝解郁,玫瑰花可以行气解郁,强肝安神,以上六味为臣药,不仅可以助君药补气升阳、疏肝解郁,还可以有效的控制酒精性心肌病所产生的心律失常,胸痛,失眠等并发症。皂角刺、大血藤活血通络、消痈止痛,桑寄生补肝强肾,炒山楂行气散瘀,川芎活血行气,配合肉桂、丹参可以治疗心脉瘀阻,胸痹心痛,肉桂补火助阳,引火归源,以补心之阳,以上六味为佐药,助君药和臣药补气升阳、行气解郁,有效成分可以抑制血管平滑肌收缩,扩张冠状动脉,增加冠脉血流量,改善心肌病的缺氧以及疼痛现象。香附、生甘草理气舒郁、调和肝胃,引药归经,在此方中共为使药。方中诸药配伍、君臣协力、佐使共辅,使之具有解毒散瘀,补气升阳,疏肝解郁的功效,能够有效治疗酒精性心肌病。
本发明药物原料用量是经发明人进行大量摸索总结得出的,各原料用量为在下述重量份范围都具有较好的疗效:葛根10-20份、丹参19-29份、黄芪25-35份、柴胡7-17份、当归10-20份、白芍10-20份、炒白术13-23份、茯苓10-20份、干姜10-20份、薄荷4-14份、玫瑰花4-14份、皂角刺15-25份、大血藤15-25份、桑寄生13-23份、炒山楂19-29份、川芎10-20份、肉桂3-9份、香附7-17份、生甘草3-9份。 其中优选为:葛根15份、丹参24份、黄芪30份、柴胡12份、当归15份、白芍15份、炒白术18份、茯苓15份、干姜15份、薄荷9份、玫瑰花9份、皂角刺20份、大血藤20份、桑寄生18份、炒山楂24份、川芎15份、肉桂6份、香附12份、生甘草6份。
本发明药物可以采用中药制剂的常规制备工艺,可制成任何一种药剂学上所说的剂型,如丸剂、散剂、片剂、胶囊剂、颗粒剂、糖浆剂、口服液等。例如可以将这些原料药研成粉末状混合均匀制成散剂冲服;可以用水煎,经过滤得滤液,加入防腐剂制成口服液;必要时也可以直接服用汤剂。
将上述各中药原料制成本发明中药胶囊剂优选的生产方法是:
步骤一:按本发明重量配比,称取葛根、白芍、炒白术、干姜、皂角刺放入非铁质容器中,加入10倍体积的水,先用武火将水煎开,煎煮约30分钟,然后加入柴胡、大血藤、桑寄生、炒山楂、肉桂、香附,以及用纱布包好的茯苓,转为文火煎煮约40分钟,最后将薄荷、玫瑰、生甘草加入水中,煎煮约10分钟,合并两次煎液,滤过;将所得滤液浓缩至75-85℃时,加入75%乙醇,放置沉淀,过滤,弃沉淀,滤液回收乙醇,在60℃环境下相对密度1.13~1.20的稠膏;
步骤二:将丹参、黄芪、当归、川芎研磨粉碎至120目筛;
步骤三:将步骤一所得稠膏进行真空干燥后,粉碎成细粉至120目筛,掺入步骤二所得细粉混合均匀,将粘合剂(PEG6000)混合的细粉中,烘干、整粒,混合均匀,装入胶囊壳中,既得治疗酒精性心肌病的胶囊剂。
本发明药物具有解毒散瘀,补气升阳,疏肝解郁的功效,且具有疗效好,治疗方式简单,治愈率高,价格低廉,不易反复的特点。据对临床120例患者观察统计,使用本发明药物一个疗程后总有效率90%,两个疗程后总有效率97.5%。
具体实施方式
实施例一、葛根10份、丹参19份、黄芪25份、柴胡7份、当归10份、白芍10份、炒白术13份、茯苓10份、干姜10份、薄荷4份、玫瑰花4份、皂角刺15份、大血藤15份、桑寄生13份、炒山楂19份、川芎10份、肉桂3份、香附7份、生甘草3份。
实施例二、葛根15份、丹参24份、黄芪30份、柴胡12份、当归15份、白芍15份、炒白术18份、茯苓15份、干姜15份、薄荷9份、玫瑰花9份、皂角刺20份、大血藤20份、桑寄生18份、炒山楂24份、川芎15份、肉桂6份、香附12份、生甘草6份。
实施例三、葛根20份、丹参29份、黄芪35份、柴胡17份、当归20份、白芍20份、炒白术23份、茯苓20份、干姜20份、薄荷14份、玫瑰花14份、皂角刺25份、大血藤25份、桑寄生23份、炒山楂29份、川芎20份、肉桂9份、香附17份、生甘草9份。
下面是患者使用本发明药物的临床统计资料:
一、一般资料
2012年12月至2014年2月收治门诊酒精性心肌病的患者共240例,均为男性,年龄36-63岁,将患者随机分为观察组和对照组,两组患者年龄、病程等各项基本资料基本相同,差异无统计学意义(P>0.05)。
二、治疗方法:
1、观察组按照本发明药物实施例二,以及优选的制备方法制备的胶囊剂,一天三次,每次两粒,温服。15日为一个疗程。
2、对照组按照CN 103550586 A中治疗酒精性心肌病的中药组合物制成的颗粒剂,温开水送服,每日2次,每次服用10克。
三、疗效评定标准:
参照 《中药新药研究指导原则》 和 NYNA 分级标准制定
1、治愈:临床主要症状、体征明显好转,心功能提高2级以上;
2、有效:症状好转,心功能提高1级;
3、无效:主要症状无改善或病情恶化。
四、观察组结果统计
对照组结果统计
其中:总有效率=治愈率+好转率
使用两个疗程后两组患者的疗效对比情况
通过对比两组患者的治疗总有效率可以发现观察组明显高于对照组,由此说明,本发明中药在治疗酒精性心肌病具有良好的临床效果,能有效提高治疗的治愈率,值得在临床应用上推广。
典型病例及疗效:
病例一、李某,男,50岁,一生没有其他的喜好,就是爱“喝两口”,每天每顿饭,无论有无下酒菜,都要美滋滋地喝上几两白酒,几十年如一日,近几年,患者开始感觉胸前区闷痛,并伴有间断心悸、心慌、活动后憋闷,起初他并没有在意,最近因一次大量饮酒,突然感觉心脏非常难受,家人急忙送往医院,被诊断为酒精性心肌病,并伴有肝硬化,在家人的极力劝说下开始戒酒,并选择中药治疗,来我处就诊,使用本发明中药制剂2个疗程后,患者自述诸症平复,胸闷气短现象缓解,继续服药一个疗程后,去医院复查心电图示心律整齐,症状完全消失,随访半年,未见复发,痊愈。
病例二、胡某,男,38岁,因几年前生意变故,家庭也出现危机,心理上收到严重的打击,整日用酒精麻痹自己,经常什么都不吃,就开始喝酒,半年多过去了,胡某不但精神萎靡,而且身体出现极度的不适,检查得出酒精肝,患者并未积极治疗,后又出现胸闷、气短、心悸、眩晕等症状,父母带其去医院检查,确诊为酒精性心肌病,父母劝导患者戒酒,并与此同时患者使用本发明中药制剂,两个疗程后,自述症状减轻,心悸、胸闷的症状缓解,继续服药一个疗程,去医院检查,症状消失,心电图正常,未发现异样,痊愈。
Claims (4)
1.一种治疗酒精性心肌病的中药制剂,其特征在于,该中药制剂是由以下重量份的药物制成:葛根10-20份、丹参19-29份、黄芪25-35份、柴胡7-17份、当归10-20份、白芍10-20份、炒白术13-23份、茯苓10-20份、干姜10-20份、薄荷4-14份、玫瑰花4-14份、皂角刺15-25份、大血藤15-25份、桑寄生13-23份、炒山楂19-29份、川芎10-20份、肉桂3-9份、香附7-17份、生甘草3-9份。
2.根据权利要求1所述的治疗酒精性心肌病的中药制剂,其特征在于,由以下重量份的药物制成:葛根15份、丹参24份、黄芪30份、柴胡12份、当归15份、白芍15份、炒白术18份、茯苓15份、干姜15份、薄荷9份、玫瑰花9份、皂角刺20份、大血藤20份、桑寄生18份、炒山楂24份、川芎15份、肉桂6份、香附12份、生甘草6份。
3.根据权利要求1或2所述的治疗酒精性心肌病的中药制剂,其特征在于:所述中药制剂为胶囊剂。
4.一种用于酒精性心肌病的中药组合物的制备方法,其特征在于,制备方法如下:步骤一:按本发明重量配比,称取葛根、白芍、炒白术、干姜、皂角刺放入非铁质容器中,加入10倍体积的水,先用武火将水煎开,煎煮约30分钟,然后加入柴胡、大血藤、桑寄生、炒山楂、肉桂、香附,以及用纱布包好的茯苓,转为文火煎煮约40分钟,最后将薄荷、玫瑰、生甘草加入水中,煎煮约10分钟,合并两次煎液,滤过;将所得滤液浓缩至75-85℃时,加入75%乙醇,放置沉淀,过滤,弃沉淀,滤液回收乙醇,在60℃环境下相对密度1.13~1.20的稠膏;步骤二:将丹参、黄芪、当归、川芎研磨粉碎至120目筛;步骤三:将步骤一所得稠膏进行真空干燥后,粉碎成细粉至120目筛,掺入步骤二所得细粉混合均匀,将粘合剂(PEG6000)混合的细粉中,烘干、整粒,混合均匀,装入胶囊壳中,既得治疗酒精性心肌病的胶囊剂。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410535988.1A CN104258351A (zh) | 2014-10-13 | 2014-10-13 | 一种治疗酒精性心肌病的中药制剂及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410535988.1A CN104258351A (zh) | 2014-10-13 | 2014-10-13 | 一种治疗酒精性心肌病的中药制剂及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104258351A true CN104258351A (zh) | 2015-01-07 |
Family
ID=52150008
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410535988.1A Pending CN104258351A (zh) | 2014-10-13 | 2014-10-13 | 一种治疗酒精性心肌病的中药制剂及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104258351A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104840891A (zh) * | 2015-05-28 | 2015-08-19 | 王丽平 | 一种用于酒精性心肌病的中药制剂及其制备方法 |
| CN105816830A (zh) * | 2016-03-24 | 2016-08-03 | 杨万勇 | 一种用于治疗肥厚型梗阻性心肌病的中药制剂及制备方法 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102524781A (zh) * | 2012-01-05 | 2012-07-04 | 北京同仁堂国际药业有限公司 | 具有解酒作用的食用组合物及其制备方法 |
| CN102846937A (zh) * | 2012-08-31 | 2013-01-02 | 霍山县中医院 | 一种治疗扩张型心肌病疾病的中药 |
-
2014
- 2014-10-13 CN CN201410535988.1A patent/CN104258351A/zh active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102524781A (zh) * | 2012-01-05 | 2012-07-04 | 北京同仁堂国际药业有限公司 | 具有解酒作用的食用组合物及其制备方法 |
| CN102846937A (zh) * | 2012-08-31 | 2013-01-02 | 霍山县中医院 | 一种治疗扩张型心肌病疾病的中药 |
Non-Patent Citations (1)
| Title |
|---|
| 许文莉等: "中西医结合治疗酒精性肝硬化并酒精性心肌病1例", 《中国民间疗法》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104840891A (zh) * | 2015-05-28 | 2015-08-19 | 王丽平 | 一种用于酒精性心肌病的中药制剂及其制备方法 |
| CN105816830A (zh) * | 2016-03-24 | 2016-08-03 | 杨万勇 | 一种用于治疗肥厚型梗阻性心肌病的中药制剂及制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103316208B (zh) | 具有补气养血、抗衰老、延年益寿的中药制剂 | |
| CN103816498A (zh) | 一种治疗睡眠障碍的中药混合物 | |
| CN104491759A (zh) | 一种治疗偏头痛的中药组合物及其制备方法 | |
| CN101085242B (zh) | 一种治疗口腔溃疡的中药组合物 | |
| CN104491755A (zh) | 一种治疗腹胀的中药组合物及其制备方法 | |
| CN104940740A (zh) | 一种治疗多囊卵巢综合征的中药组合物及其制备方法 | |
| CN104666579A (zh) | 一种治疗膝关节滑膜炎的中药组合物及其制备方法 | |
| CN101095768B (zh) | 一种治疗中老年原发性高血压的中药胶囊 | |
| CN1250275C (zh) | 一种治疗恶性肿瘤的中药制剂及其制备方法 | |
| CN102579794A (zh) | 治疗慢性心力衰竭的中药制剂、片剂、口服液、煎剂及制备方法 | |
| CN104258351A (zh) | 一种治疗酒精性心肌病的中药制剂及其制备方法 | |
| CN105943705A (zh) | 一种治疗类风湿性关节炎的中药组合物及其制备方法 | |
| CN104353051A (zh) | 一种治疗胃痛的中药制剂及其制备方法 | |
| CN104826074A (zh) | 一种用于窦性心动过缓的中药制剂及其制备方法 | |
| CN101129818A (zh) | 一种内服治疗口腔溃疡的中药汤剂 | |
| CN104435225A (zh) | 一种治疗高血压的中药及其胶囊的制备方法 | |
| CN104689252A (zh) | 一种治疗韦格肉芽肿的中药制剂及其制备方法 | |
| CN104524535A (zh) | 一种治疗慢性肺源性心脏病的中药组合物及其制备方法 | |
| CN104857370A (zh) | 一种治疗乳腺癌症的中药组合物 | |
| CN112641878A (zh) | 一种治疗贫血的中药组合物及其制备方法 | |
| CN104127670A (zh) | 一种治疗心律不齐的中药汤剂 | |
| CN104116908A (zh) | 一种治疗心律不齐的中药汤剂 | |
| CN104958677A (zh) | 一种治疗膜性肾病的中药制剂及其制备方法 | |
| CN105727158A (zh) | 一种治疗淋巴瘤的中药胶囊及其制备方法 | |
| CN102309725B (zh) | 治疗乙肝肝硬化中药制剂及制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150107 |